⌘K
Loading ticker…
Ginkgo Bioworks Holdings, Inc. · Healthcare · Pharmaceutical Products
As of 2026-06-26, Ginkgo Bioworks Holdings, Inc. (DNA) has a 3-month relative strength percentile of 92 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 58. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 9.1%, relative volume 1.88×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
3m RS is 92, Market Stance is mixed at 47, A/D rating B
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY diluted average shares. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Strong relative strength, but attention is quiet relative to this name’s own recent norm. Academic work links low public attention to better forward returns on average — context to weigh, not a forecast.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
DNA is held by 5 ETFs as of Mar 2026. Top owner: VTI at 0.00% weight, $8M notional. Top 3 carry $18M.
Top 5 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.00% | $8M |
| IWMiShares Russell 2000 ETF | 0.01% | $6M |
| VXFVanguard Extended Market ETF | 0.00% | $3M |
| ITOTiShares Core S&P Total U.S. Stock Market ETF | 0.00% | $394K |
| IWOiShares Russell 2000 Growth ETF | 0.00% | $791 |
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | DNA Jan avg: 7.74% median: 11.66% win: 75% σ: 26.87% n: 4 2022-04-12 → 2026-05-29 | DNA Feb avg: -15.52% median: -24.68% win: 25% σ: 28.17% n: 4 2022-04-12 → 2026-05-29 | DNA Mar avg: -18.30% median: -16.60% win: 0% σ: 10.74% n: 4 2022-04-12 → 2026-05-29 | DNA Apr avg: 4.49% median: -8.27% win: 40% σ: 27.33% n: 5 2022-04-12 → 2026-05-29 | DNA May avg: 0.02% median: 6.21% win: 60% σ: 26.04% n: 5 2022-04-12 → 2026-05-29 | DNA Jun avg: 5.03% median: -2.50% win: 50% σ: 44.38% n: 4 2022-04-12 → 2026-05-29 (current) | DNA Jul avg: 21.40% median: 18.48% win: 100% σ: 9.41% n: 4 2022-04-12 → 2026-05-29 | DNA Aug avg: -18.07% median: -6.36% win: 0% σ: 25.31% n: 4 2022-04-12 → 2026-05-29 | DNA Sep avg: 7.56% median: 15.53% win: 75% σ: 20.36% n: 4 2022-04-12 → 2026-05-29 | DNA Oct avg: -13.55% median: -11.70% win: 0% σ: 7.61% n: 4 2022-04-12 → 2026-05-29 | DNA Nov avg: -11.83% median: -16.47% win: 25% σ: 20.21% n: 4 2022-04-12 → 2026-05-29 | DNA Dec avg: 4.59% median: 1.21% win: 50% σ: 21.44% n: 4 2022-04-12 → 2026-05-29 |